These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32837881)

  • 1. Ventilator-associated pneumonia involving
    Fernandez NB; Caceres DH; Beer KD; Irrazabal C; Delgado G; Farias L; Chiller TM; Verweij PE; Stecher D
    Med Mycol Case Rep; 2021 Mar; 31():19-23. PubMed ID: 32837881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient.
    Blaize M; Mayaux J; Nabet C; Lampros A; Marcelin AG; Thellier M; Piarroux R; Demoule A; Fekkar A
    Emerg Infect Dis; 2020 Jul; 26(7):1636-1637. PubMed ID: 32343223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal VAP-related pulmonary aspergillosis by
    Trovato L; Calvo M; Migliorisi G; Astuto M; Oliveri F; Oliveri S
    Respir Med Case Rep; 2021; 32():101367. PubMed ID: 33619451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal aspergillosis complicating severe SARS-CoV-2 infection: A case report.
    Schein F; Munoz-Pons H; Mahinc C; Grange R; Cathébras P; Flori P
    J Mycol Med; 2020 Dec; 30(4):101039. PubMed ID: 32861584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Rates of Ventilator-Associated Pneumonia and COVID-19 Associated Pulmonary Aspergillosis in Critically Ill Patients with SARS-CoV2 Infection in the Second Wave: A Retrospective Chart Review.
    Boyd S; Sheng Loh K; Lynch J; Alrashed D; Muzzammil S; Marsh H; Masoud M; Bin Ihsan S; Martin-Loeches I
    Antibiotics (Basel); 2022 May; 11(5):. PubMed ID: 35625276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis.
    Lamoth F; Lewis RE; Walsh TJ; Kontoyiannis DP
    J Infect Dis; 2021 Nov; 224(10):1631-1640. PubMed ID: 33770176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 associated pulmonary aspergillosis in ICU patients: Report of five cases from Argentina.
    Benedetti MF; Alava KH; Sagardia J; Cadena RC; Laplume D; Capece P; Posse G; Nusblat AD; Cuestas ML
    Med Mycol Case Rep; 2021 Mar; 31():24-28. PubMed ID: 33312852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease.
    Razazi K; Arrestier R; Haudebourg AF; Benelli B; Carteaux G; Decousser JW; Fourati S; Woerther PL; Schlemmer F; Charles-Nelson A; Botterel F; de Prost N; Mekontso Dessap A
    Crit Care; 2020 Dec; 24(1):699. PubMed ID: 33339526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Care bundles for improving outcomes in patients with COVID-19 or related conditions in intensive care - a rapid scoping review.
    Smith V; Devane D; Nichol A; Roche D
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013819. PubMed ID: 33348427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus Disease 2019 (COVID-19) in a Patient with Disseminated Histoplasmosis and HIV-A Case Report from Argentina and Literature Review.
    Messina FA; Marin E; Caceres DH; Romero M; Depardo R; Priarone MM; Rey L; Vázquez M; Verweij PE; Chiller TM; Santiso G
    J Fungi (Basel); 2020 Nov; 6(4):. PubMed ID: 33182836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Patients Co-infected with Severe Acute Respiratory Syndrome Coronavirus 2 and Dengue Virus, Buenos Aires, Argentina, March-June 2020.
    Carosella LM; Pryluka D; Maranzana A; Barcan L; Cuini R; Freuler C; Martinez A; Equiza TR; Peria CR; Yahni D; Stryjewski ME;
    Emerg Infect Dis; 2021 Feb; 27(2):348-351. PubMed ID: 33347804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive pulmonary aspergillosis among intubated patients with SARS-CoV-2 or influenza pneumonia: a European multicenter comparative cohort study.
    Rouzé A; Lemaitre E; Martin-Loeches I; Povoa P; Diaz E; Nyga R; Torres A; Metzelard M; Du Cheyron D; Lambiotte F; Tamion F; Labruyere M; Boulle Geronimi C; Luyt CE; Nyunga M; Pouly O; Thille AW; Megarbane B; Saade A; Magira E; Llitjos JF; Ioannidou I; Pierre A; Reignier J; Garot D; Kreitmann L; Baudel JL; Voiriot G; Plantefeve G; Morawiec E; Asfar P; Boyer A; Mekontso-Dessap A; Makris D; Vinsonneau C; Floch PE; Marois C; Ceccato A; Artigas A; Gaudet A; Nora D; Cornu M; Duhamel A; Labreuche J; Nseir S;
    Crit Care; 2022 Jan; 26(1):11. PubMed ID: 34983611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 and Aspergillus section Fumigati coinfection in an immunocompetent patient treated with corticosteroids.
    Sasoni N; Rodriguez Müller M; Posse G; González J; Leonardelli F; Garcia-Effron G
    Rev Iberoam Micol; 2021; 38(1):16-18. PubMed ID: 33500209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subacute Aspergillosis "Fungal Balls" Complicating COVID-19.
    Patti RK; Dalsania NR; Somal N; Sinha A; Mehta S; Ghitan M; Seneviratne C; Kupfer Y
    J Investig Med High Impact Case Rep; 2020; 8():2324709620966475. PubMed ID: 33054445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological and clinical characteristics of fifty-six cases of COVID-19 in Liaoning Province, China.
    Wang JB; Wang HT; Wang LS; Li LP; Xv J; Xv C; Li XH; Wu YH; Liu HY; Li BJ; Yu H; Tian X; Zhang ZY; Wang Y; Zhao R; Liu JY; Wang W; Gu Y
    World J Clin Cases; 2020 Nov; 8(21):5188-5202. PubMed ID: 33269255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 associated with pulmonary aspergillosis: A literature review.
    Lai CC; Yu WL
    J Microbiol Immunol Infect; 2021 Feb; 54(1):46-53. PubMed ID: 33012653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-Associated Pulmonary Aspergillosis (CAPA).
    Dimopoulos G; Almyroudi MP; Myrianthefs P; Rello J
    J Intensive Med; 2021 Oct; 1(2):71-80. PubMed ID: 36785564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics.
    Kamel Boulos MN; Geraghty EM
    Int J Health Geogr; 2020 Mar; 19(1):8. PubMed ID: 32160889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
    Erami M; Hashemi SJ; Raiesi O; Fattahi M; Getso MI; Momen-Heravi M; Daie Ghazvini R; Khodavaisy S; Parviz S; Mehri N; Babaei M
    Infection; 2023 Feb; 51(1):223-230. PubMed ID: 36107379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
    Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
    Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.